Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer
摘要:
The bisamide class of kinase inhibitors was identified as being active against CSF-1R. The synthesis and SAR of pyridyl and thiazolyl bisamides is reported, along with the pharmacokinetic properties and in vivo activity of selected examples. (C) 2008 Elsevier Ltd. All rights reserved.
Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer
作者:David A. Scott、Brian M. Aquila、Geraldine A. Bebernitz、Donald J. Cook、Les A. Dakin、Tracy L. Deegan、Maureen M. Hattersley、Stephanos Ioannidis、Paul D. Lyne、Charles A. Omer、Minwei Ye、XiaoLan Zheng
DOI:10.1016/j.bmcl.2008.07.093
日期:2008.9
The bisamide class of kinase inhibitors was identified as being active against CSF-1R. The synthesis and SAR of pyridyl and thiazolyl bisamides is reported, along with the pharmacokinetic properties and in vivo activity of selected examples. (C) 2008 Elsevier Ltd. All rights reserved.